As a part of my series about “The Future of Healthcare” I had the pleasure of interviewing Joseph C. Sardano, Chief Executive Officer, Sensus Healthcare Inc. A recognized leader in the healthcare industry, Joe Sardano has spent more than 30 years in management and marketing. He has a successful history of introducing and commercializing new technologies and services in many areas, including electronic brachytherapy, PET and PET/CT, SPECT, MRI, lithotripsy and digital radiography. Before joining Sensus Healthcare, Sardano held leadership and management roles at CTI Molecular Imaging, GE Medical Systems, Siemens Medical Systems, Elscint Inc and Toshiba America Medical Systems, among others.
Can you tell us a story about what brought you to this specific career path?
With more than 30 years in healthcare management, it had been a lifelong dream of mine to launch Sensus Healthcare with my best friends, with the mission of providing highly effective, yet noninvasive, treatment options for both non-melanoma skin cancers and keloids. This resonated with us at its core. There are so many patients all over the world who are “surgically fatigued,” and Mohs surgery as the current gold standard of treatment just doesn’t work for them or allow them to have a better quality of life. I greatly admire, respect and value the strong work ethic, integrity and insights that the Sensus team has to offer, and all of this is ultimately what led me to create this company.
Can you share the most interesting story that happened to you since you began your career?
When the original developer of Superficial Radiation Therapy (SRT) decided to sell us the rights, it was a good feeling, because he had confidence and trust in the Sensus team to share this great technology that people needed. This has been something that has stuck with me since Day One and continues to be the driving force behind SRT and helping to treat people with skin cancer and keloids. I really believe that what we have done with the company so far is the story — and we are far from the end.
Can you tell us about your “Big Idea That Might Change The World”?
SRT provides a noninvasive, cost-effective treatment for non-melanoma skin cancers and keloids to patients all over the world. It is virtually painless and doesn’t involve cutting, bleeding, stitching or anesthesia. There is also no risk of infection or scarring and no need for reconstructive plastic surgery. This is a game-changer for both patients and doctors, because not only does SRT offer comparable cure and recurrence rates to that of Mohs surgery, but it also allows for value-based care, which is where our healthcare system is headed today.
How do you think this will change the world?
With SRT, we are providing patients with a nonsurgical treatment option that uses painless, low-dose radiation that only goes skin deep to destroy cancer cells — without damaging health tissue — to give an aesthetically pleasing look and feel, as well as allow patients to continue their lifestyles with little downtime post-treatment. This is particularly important for elderly patients, many of whom have diabetes and cardiovascular disease, which makes them poor candidates for surgery. Additionally, patients with keloids have scars that can significantly impact their physical appearance and cause self-consciousness, anxiety and depression. All in all, SRT offers patients another option in the battle against skin cancer and keloids.
Can you share with our readers what you think are the most important “success habits” or “success mindsets”?
Appreciate your support system. Everyone relies on someone else to help them get through the day, and it’s important to remember and appreciate those who assist in your success. I am thankful for an outstanding team that supports and lifts up our entire community, making sure that we provide a safe and innovative platform across all levels of our business, especially for our patients and physicians.
Thank you so much for joining us. This was very inspirational.